Saggar Rajeev sold $6.0M of LQDA
Saggar Rajeev (Chief Medical Officer) sold 79,534 shares of Liquidia Corp (LQDA) at an average of $75.09 ($74.06–$76.84, $5.97M total) across 2 trades over 2026-08-17 to 2026-08-19.
How this was made
The 30-second read
Why it matters
The insider sale provides fresh data on insider sentiment, which traders may use to adjust short-term positions.
Market read
New insider sale information for a small-cap biotech, modest relevance for traders tracking insider activity.
What to watch
No accompanying corporate news; the sale may be routine and not indicative of future performance.
Background
SEC Form 4 filing discloses insider transactions for public companies.
Ticker impact
Chief Medical Officer Saggar Rajeev sold 79,534 shares for $5.97M, reducing his stake to 142,265 shares.
Possible modest downside pressure in the near term.
CMO is a senior insider; a $6M sale is material for a small-cap biotech, but not large enough to trigger a major move.
Market effects
May raise concerns for biotech sector investors monitoring insider activity.
Limited to U.S. biotech investors.
Low global relevance.
Counterpoint
The sale could be unrelated to confidence, perhaps for personal financial planning.
Key entities
- CompanyLiquidia Corp
Biopharmaceutical company developing drug delivery platforms.
- IndividualSaggar Rajeev
Chief Medical Officer of Liquidia Corp.